Login / Signup

Phillyrin improves myocardial remodeling in salt-sensitive hypertensive mice by reducing endothelin1 signaling.

Qingman LuoQiao LiuKecheng TangBin ZhongShengqian YangXiaohui Li
Published in: The Journal of pharmacy and pharmacology (2024)
Our research highlights the therapeutic capabilities of phillyrin in the treatment of myocardial remodeling through the reduction of ET-1 signaling. These results contribute to the advancement of novel applications for phillyrin and establish a solid conceptual basis for future investigations in this area.
Keyphrases
  • left ventricular
  • blood pressure
  • current status
  • type diabetes
  • high fat diet induced
  • metabolic syndrome
  • replacement therapy
  • atrial fibrillation